US Patent Issued to ITabMed (HK) on Nov. 4 for "Anti-CD19 and anti-CD3 bispecific antigen binding proteins and uses thereof" (Chinese Inventors)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,460,000, issued on Nov. 4, was assigned to ITabMed (HK) Ltd. (Hong Kong).

"Anti-CD19 and anti-CD3 bispecific antigen binding proteins and uses thereof" was invented by Zhihua Huang (Shanghai), Yiqun Rao (Shanghai), Wuzhong Shen (Shanghai), Yumin Cui (Shanghai) and Xiaoqiang Yan (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides bispecific antigen binding proteins (BSAPs) that specifically bind to CD3 and a tumor antigen (e.g., CD19). The present invention also provides uses of the BSAPs for the preparation of pharmaceutical compositions, methods of treating cancer, and kits comprising the BSAPs."

The patent was filed...